Search research articles
Contact Us
Filters
Showing results (41-50 of 90) with videos related to
Page
of 9
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
September 10, 2005
Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes
Jianying He, Isao Usui, Ken Ishizuka, et al.
The American Journal of the Medical Sciences
|
July 10, 2024
Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide
Kanako Kato, Teruo Jojima, Takahiko Kogai, et al.
Cell Metabolism
|
April 30, 2015
SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
Myeong Jin Yoon, Mitsukuni Yoshida, Sean Johnson, et al.
The Journal of Biological Chemistry
|
June 7, 2002
Involvement of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells
Fujun Liu, Isao Usui, Lui Guojing Evans, et al.
Diabetes
|
March 1, 2007
Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression
Yukiko Kanatani, Isao Usui, Ken Ishizuka, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
March 20, 2022
Transcription of cytochrome P450 46A1 in NIH3T3 cells is negatively regulated by FBS
Yasutake Shinohara, Hiromi Ando, Masamitsu Maekawa, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
|
August 12, 2024
Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin
Yasutake Shinohara, Teruo Jojima, Yusuke Kamiga, et al.
Diabetes, Obesity & Metabolism
|
September 5, 2018
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
Masanori Shimizu, Kunihiro Suzuki, Kanako Kato, et al.
Internal Medicine (Tokyo, Japan)
|
April 8, 2026
Alcoholic Ketoacidosis Accompanied by Acute Gastric Dilation in a Patient with type 2 Diabetes on an SGLT2 Inhibitor and Chronic Alcoholic Abuse
Masahiro Saito, Hidetaka Kurai, Kanako Suda, et al.
Journal of Diabetes and Its Complications
|
November 30, 2023
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor
Sho Wakamatsu, Teruo Jojima, Masaaki Hashiguchi, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 90) with videos related to
Sort By:
Page
of 9
Molecular Endocrinology (Baltimore, Md.)
|
September 10, 2005
Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes
Jianying He, Isao Usui, Ken Ishizuka, et al.
The American Journal of the Medical Sciences
|
July 10, 2024
Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide
Kanako Kato, Teruo Jojima, Takahiko Kogai, et al.
Cell Metabolism
|
April 30, 2015
SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
Myeong Jin Yoon, Mitsukuni Yoshida, Sean Johnson, et al.
The Journal of Biological Chemistry
|
June 7, 2002
Involvement of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells
Fujun Liu, Isao Usui, Lui Guojing Evans, et al.
Diabetes
|
March 1, 2007
Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression
Yukiko Kanatani, Isao Usui, Ken Ishizuka, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
March 20, 2022
Transcription of cytochrome P450 46A1 in NIH3T3 cells is negatively regulated by FBS
Yasutake Shinohara, Hiromi Ando, Masamitsu Maekawa, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
|
August 12, 2024
Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin
Yasutake Shinohara, Teruo Jojima, Yusuke Kamiga, et al.
Diabetes, Obesity & Metabolism
|
September 5, 2018
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
Masanori Shimizu, Kunihiro Suzuki, Kanako Kato, et al.
Internal Medicine (Tokyo, Japan)
|
April 8, 2026
Alcoholic Ketoacidosis Accompanied by Acute Gastric Dilation in a Patient with type 2 Diabetes on an SGLT2 Inhibitor and Chronic Alcoholic Abuse
Masahiro Saito, Hidetaka Kurai, Kanako Suda, et al.
Journal of Diabetes and Its Complications
|
November 30, 2023
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor
Sho Wakamatsu, Teruo Jojima, Masaaki Hashiguchi, et al.
Page
of 9